Skip to main content
OpenTrials

Clinical trial condition

Severe Acute Respiratory Syndrome

Explore clinical trials studying Severe Acute Respiratory Syndrome. Study availability and eligibility vary by location and protocol.

217 public trials 5 recruiting studies
Refine in advanced search Browse all conditions

Severe Acute Respiratory Syndrome trial results

Completed

Evaluation of the Safety and Immunogenicity of Influenza and COVID-19 Combination Vaccine

NCT04961541

Conditions
COVID-19, Coronaviridae Infections, Coronavirus Infections, +12 more
Locations
  • Paratus Clinical Research - Canberra Bruce, Australian Capital Territory, Australia
  • Paratus Clinical Research - Western Sydney Blacktown, New South Wales, Australia
  • Northern Beaches Clinical Research Brookvale, New South Wales, Australia
  • Paratus Clinical Research - Central Coast Kanwal, New South Wales, Australia
View Trial Details
Completed

AZD7442 for Inpatients With COVID-19 (An ACTIV-3/TICO Treatment Trial)

NCT05780437

Conditions
COVID-19, Coronaviridae Infections, Coronavirus Infections, +10 more
Locations
  • Banner University Medical Center Tucson (Site 206-004), 1625 N. Campbell Avenue Tucson, Arizona, United States
  • Southern Arizona VA Healthcare System (Site 074-009), 3601 S. 6th Ave. Tucson, Arizona, United States
  • Velocity Chula Vista (Site 080-034), 752 Medical Center Ct., Ste. 304 Chula Vista, California, United States
  • Community Regional Medical Center (Site 203-005), 2823 Fresno Street Fresno, California, United States
View all 124 locations
View Trial Details
Completed

Study of VXCO-100, a SARS-CoV Candidate Vaccine in Healthy Adults in the United States

NCT05870839

Conditions
COVID-19, Coronaviridae Infections, Coronavirus Infections, +12 more
Locations
  • The Hope Clinic of Emory University Decatur, Georgia, United States
  • University of Maryland, Baltimore, Center for Vaccine Development and Global Health Baltimore, Maryland, United States
  • University of Rochester Medical Center - Vaccine Research Unit Rochester, New York, United States
View Trial Details
Completed

Safety and Immunogenicity of RNA-based Vaccines Against SARS-CoV-2 Variants in Healthy Participants

NCT05004181

Conditions
COVID-19, Coronaviridae Infections, Coronavirus Infections, +16 more
Locations
  • Collaborative Neuroscience Network LLC Long Beach, California, United States
  • California Research Foundation San Diego, California, United States
  • Clinical Research Consulting, Llc Milford, Connecticut, United States
  • Stamford Therapeutics Consortium Stamford, Connecticut, United States
View all 35 locations
View Trial Details

Related conditions